Company / Interest Expense per Share
United Therapeutics Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.29
FY2023
5-year range
$0.42 / $1.29
FY2019-FY2023
Trend
+79.3%
vs FY2022
Sector context
#9 of 43
Health Care
What the data says
United Therapeutics's interest expense per share of $1.29 is higher than 79% of companies in the Health Care sector (FY2023). Increased from $0.42 to $1.29 over the past 2 years.
Based on SEC 10-K filings.
1.29 in FY2023 with a 5-year CAGR of +32.0%. Top quartile in the Health Care sector.
Increased from $0.42 to $1.29 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +34.0%
- 5-Year CAGR
- +32.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 43This company $1.29 Sector average $18.61
▼
-93.1% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 79.3% year-over-year.
- Ranks #9 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.29 | +79.3% |
| FY2022 | $0.72 | +71.9% |
| FY2021 | $0.42 | -22.0% |
| FY2020 | $0.54 | -47.2% |
| FY2019 | $1.01 | +215.4% |
| FY2018 | $0.32 | +193.9% |
| FY2017 | $0.11 | +28.4% |
| FY2016 | $0.09 | -14.6% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026